Canada - inglese - Health Canada

dmvet inc - sodium chloride - solution - 0.9g - sodium chloride 0.9g - cattle; swine (pigs); horses; cats; sheep; dogs

Canada - inglese - Health Canada

dmvet inc - sodium chloride; sodium lactate; potassium chloride; calcium chloride - solution - 6g; 3.1g; 0.3g; 0.2g - sodium chloride 6g; sodium lactate 3.1g; potassium chloride 0.3g; calcium chloride 0.2g - cattle; swine (pigs); horses; cats; sheep; dogs

Canada - inglese - Health Canada

bausch health, canada inc. - ethacrynic acid (ethacrynate sodium) - powder for solution - 50mg - ethacrynic acid (ethacrynate sodium) 50mg - loop diuretics

Malta - inglese - Medicines Authority

farmigea s.p.a via g.b. oliva, 8 56121 pisa, italy - pirenoxine sodium - eye drops - pirenoxine sodium 0.376 mg - ophthalmologicals

Canada - inglese - Health Canada

alivira animal health limited - cloprostenol (cloprostenol sodium) - solution - 0.25mg - cloprostenol (cloprostenol sodium) 0.25mg - cattle

Stati Uniti - inglese - NLM (National Library of Medicine)

mylan institutional llc - ethacrynate sodium (unii: k41myv7mpm) (ethacrynic acid - unii:m5dp350vzv) - ethacrynic acid 50 mg in 50 ml - ethacrynic acid is indicated for treatment of edema when an agent with greater diuretic potential than those commonly employed is required. all diuretics, including ethacrynic acid, are contraindicated in anuria. if increasing electrolyte imbalance, azotemia, and/or oliguria occur during treatment of severe, progressive renal disease, the diuretic should be discontinued. in a few patients this diuretic has produced severe, watery diarrhea. if this occurs, it should be discontinued and not used again. until further experience in infants is accumulated, therapy with oral and parenteral ethacrynic acid is contraindicated. hypersensitivity to any component of this product.

Stati Uniti - inglese - NLM (National Library of Medicine)

par pharmaceutical, inc. - ethacrynate sodium (unii: k41myv7mpm) (ethacrynic acid - unii:m5dp350vzv) - ethacrynate sodium is indicated for treatment of edema when an agent with greater diuretic potential than those commonly employed is required. - 1.treatment of the edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome. - 2.short-term management of ascites due to malignancy, idiopathic edema, and lymphedema. - 3.short-term management of hospitalized pediatric patients, other than infants, with congenital heart disease or the nephrotic syndrome. - 4.intravenous ethacrynate sodium is indicated when a rapid onset of diuresis is desired, e.g., in acute pulmonary edema, or when gastrointestinal absorption is impaired or oral medication is not practicable. all diuretics, including ethacrynic acid, are contraindicated in anuria. if increasing electrolyte imbalance, azotemia, and/or oliguria occur during treatment of severe, progressive renal disease, the diuretic should be discontinued. in a few patients this diuretic has produced severe, watery d

Stati Uniti - inglese - NLM (National Library of Medicine)

par pharmaceutical, inc. - ethacrynate sodium (unii: k41myv7mpm) (ethacrynic acid - unii:m5dp350vzv) - ethacrynate sodium is indicated for treatment of edema when an agent with greater diuretic potential than those commonly employed is required. - 1.treatment of the edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome. - 2.short-term management of ascites due to malignancy, idiopathic edema, and lymphedema. - 3.short-term management of hospitalized pediatric patients, other than infants, with congenital heart disease or the nephrotic syndrome. - 4.intravenous ethacrynate sodium is indicated when a rapid onset of diuresis is desired, e.g., in acute pulmonary edema, or when gastrointestinal absorption is impaired or oral medication is not practicable. all diuretics, including ethacrynic acid, are contraindicated in anuria. if increasing electrolyte imbalance, azotemia, and/or oliguria occur during treatment of severe, progressive renal disease, the diuretic should be discontinued. in a few patients this diuretic has produced severe, watery d

Stati Uniti - inglese - NLM (National Library of Medicine)

par pharmaceutical, inc. - ethacrynate sodium (unii: k41myv7mpm) (ethacrynic acid - unii:m5dp350vzv) - ethacrynate sodium is indicated for treatment of edema when an agent with greater diuretic potential than those commonly employed is required. 1.treatment of the edema associated with congestive heart failure, cirrhosis of the liver, and renal disease, including the nephrotic syndrome. 2.short-term management of ascites due to malignancy, idiopathic edema, and lymphedema. 3.short-term management of hospitalized pediatric patients, other than infants, with congenital heart disease or the nephrotic syndrome. 4.intravenous ethacrynate sodium is indicated when a rapid onset of diuresis is desired, e.g., in acute pulmonary edema, or when gastrointestinal absorption is impaired or oral medication is not practicable. all diuretics, including ethacrynic acid, are contraindicated in anuria. if increasing electrolyte imbalance, azotemia, and/or oliguria occur during treatment of severe, progressive renal disease, the diuretic should be discontinued. in a few patients this diuretic has produced severe, watery diarrhea.

Stati Uniti - inglese - NLM (National Library of Medicine)

leading pharma, llc - ethacrynate sodium (unii: k41myv7mpm) (ethacrynic acid - unii:m5dp350vzv) - ethacryname sodium is indicated for treatment of edema when as agent with greater diuretic potential than those commonly employed is required. - treatment of the edema associated with congestive heart failure, cirrhosis of the liver and renal disease, including the nephrotic syndrome. - short-term management of ascites due to malignancy, idiopathic edema, and lymphedema. - short-term management of hospitalized pediatric patients, other than infants, with congenital heart disease or the nephrotic syndrome. - intravenous ethacrynate sodium is indicated when a rapid onset of diuresis is desired, e.g., in acute pulmonary edema, or when gastrointestinal absorption is impaired or oral medication is not practicable. all diuretics, including ethacrynic acid, are contraindicated in anuria. if increasing electrolyte imbalance, azotemia, and/or oliguria occur during treatment of severe, progressive renal disease, the diuretic should be discontinued. in a few patients this diuretic has produced severe, watery diarrhea. i